DexCom Inc. (DXCM)

161.53
6.20 4.00
NASDAQ : Health Technology
Prev Close 155.35
Open 155.76
Day Low/High 155.10 / 160.09
52 Wk Low/High 105.05 / 178.45
Volume 210.76K
Avg Volume 841.80K
Exchange NASDAQ
Shares Outstanding 91.19M
Market Cap 14.08B
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)
Comcast, Lululemon, EQT and Other New Activist Investments

Comcast, Lululemon, EQT and Other New Activist Investments

Quarterly filings provide a window into new allocations made by insurgent fund managers Paul Singer, Glenn Welling, Barry Rosenstein and Keith Meister. Could M&A campaigns be next?

DexCom Announces Upcoming Conference Presentation

DexCom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate...

DexCom Launches "Call Of The Warrior" Campaign For National Diabetes Awareness Month

DexCom Launches "Call Of The Warrior" Campaign For National Diabetes Awareness Month

In honor of National Diabetes Awareness Month, DexCom, Inc. (Nasdaq: DXCM) has launched the "Call of the Warrior" campaign on social media to support those living with diabetes, a chronic disease that affects more than...

DexCom, Inc. Reports Record Third Quarter 2017 Financial Results

DexCom, Inc. Reports Record Third Quarter 2017 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended September 30, 2017.

Weekly Roundup

Markets ride a tide of earnings. In the portfolio, we trimmed 3 positions.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: GSK, OPB, RES, SIX, TUP Downgrades: AXS, BPL, DXCM, KRA, OI, TRK, WMS Initiations: NTB Read on to get TheStreet Quant Ratings' detailed report:

DexCom Announces Upcoming Conference Presentation

DexCom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Kevin Sayer, President and Chief Executive Officer, will present an...

DexCom Schedules Third Quarter 2017 Earnings Release And Conference Call For November 1, 2017 At 4:30 P.m. Eastern Time

DexCom Schedules Third Quarter 2017 Earnings Release And Conference Call For November 1, 2017 At 4:30 P.m. Eastern Time

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2017 financial results after market close on Wednesday, November 1, 2017.

The Case for the Bears: Cramer's 'Mad Money' Recap (Wed 10/4/17)

The Case for the Bears: Cramer's 'Mad Money' Recap (Wed 10/4/17)

Wait! What?! Jim Cramer ticks off the potential problems that smart investors should be on the lookout for.

Jim Cramer: We Remain Excited About Abbott Laboratories for Action Alerts Plus

Jim Cramer: We Remain Excited About Abbott Laboratories for Action Alerts Plus

Jim Cramer explains why his Action Alerts Plus charitable portfolio is hanging on to Abbott Laboratories.

Buy Abbott Labs as It Obliterates DexCom Stock, Jim Cramer Says

Buy Abbott Labs as It Obliterates DexCom Stock, Jim Cramer Says

Shares of DexCom are down more than 35% Thursday after Abbott Labs secured FDA approval for its new glucose monitoring system. Jim Cramer calls Abbott Labs a buy.

Noteworthy Thursday Option Activity: DXCM, AQMS, TCX

Noteworthy Thursday Option Activity: DXCM, AQMS, TCX

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in DexCom Inc , where a total volume of 6,159 contracts has been traded thus far today, a contract volume which is representative of approximately 615,900 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 59.6% of DXCM's average daily trading volume over the past month, of 1.0 million shares.

Abbott Climbs on 'Dose' of Good News; Raising Our Target

FDA approval and dosing label for FreeStyle Libre glucose monitoring system makes it a major player in the U.S. market.

DexCom Opens Data Platform And Launches Developer Program To Fuel Diabetes App Innovation

DexCom Opens Data Platform And Launches Developer Program To Fuel Diabetes App Innovation

DexCom, Inc. (Nasdaq: DXCM), the leader in continuous glucose monitoring (CGM), announced today the availability of a public API, empowering third-party developers to connect patient-authorized CGM data into a broad range...

DexCom Announces Upcoming Conference Presentation

DexCom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and...

Fitbit And Dexcom To Develop Continuous Glucose Monitoring (CGM) Experience For People Living With Diabetes

Fitbit And Dexcom To Develop Continuous Glucose Monitoring (CGM) Experience For People Living With Diabetes

Fitbit (NYSE:FIT), the leading global wearables brand, and DexCom, Inc.

New Study Shows People With Type 2 Diabetes Benefit From Continuous Glucose Monitoring

New Study Shows People With Type 2 Diabetes Benefit From Continuous Glucose Monitoring

DexCom, Inc. (Nasdaq: DXCM), announced today the publication of a new study that shows people with Type 2 diabetes on a multiple daily injection (MDI) insulin therapy benefit from the use of continuous glucose monitoring...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BETR, CG, DXCM, ITG, JLL, KEM, NUS, STRL, SUM, SWIR Downgrades: DVA, GHC, ISCA, QRVO, RDC, SCMP Initiations: ASPU Read on to get TheStreet Quant Ratings' detailed report:

DexCom Announces Upcoming Conference Presentation

DexCom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Matthew Dolan, VP Corporate Development, will present an update on the...

DexCom, Inc. Reports Second Quarter 2017 Financial Results

DexCom, Inc. Reports Second Quarter 2017 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended June 30, 2017.

DexCom Announces Upcoming Conference Presentation

DexCom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate...

DexCom Schedules Second Quarter 2017 Earnings Release And Conference Call For August 1, 2017 At 4:30 P.m. Eastern Time

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2017 financial results after market close on Tuesday, August 1, 2017.

Apple Watch Is on Its Way to Becoming a $6 Billion Business, but Is That Really Enough?

Apple Watch Is on Its Way to Becoming a $6 Billion Business, but Is That Really Enough?

After a slump early last year, the smartwatch's sales have been rebounding.

New Study Shows Adults With Type 1 And Type 2 Diabetes On Multiple Daily Injections (MDI) Benefit From CGM

DexCom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM) for people with diabetes, is presenting important clinical data for patients with type 1 and type 2 diabetes, at the American Diabetes...

Dexcom To Add Ambulatory Glucose Profile (AGP) To Dexcom CLARITY®

DexCom, Inc. (NASDAQ: DXCM), the leader in continuous glucose monitoring (CGM) for people with diabetes, announced today that it incorporated Ambulatory Glucose Profile (AGP) into its Dexcom CLARITY software.

DexCom Shares Rise After FDA Approves G5 Mobile App for Android Devices

DexCom Shares Rise After FDA Approves G5 Mobile App for Android Devices

DexCom's app tracks glucose levels for people with diabetes.

DexCom Announces FDA Approval Of G5 Mobile App For Android Devices

DexCom, Inc. (Nasdaq: DXCM) the leader in continuous glucose monitoring (CGM) for people with diabetes, is pleased to announce the Food and Drug Administration (FDA) approval of the Dexcom G5 mobile app for Android...

Apple Watch Appears on Its Way to Becoming a $6 Billion Business

Apple Watch Appears on Its Way to Becoming a $6 Billion Business

After a slump early last year, the smartwatch's sales have been rebounding. New features unveiled at Apple's WWDC conference could aid its momentum later this year.

DexCom Stock Surging on Apple Watch Partnership

DexCom Stock Surging on Apple Watch Partnership

Apple will release a new Bluetooth API for the Apple Watch.

Markets Down? Get Used to It: Cramer's 'Mad Money' Recap (Wednesday 5/17/17)

Markets Down? Get Used to It: Cramer's 'Mad Money' Recap (Wednesday 5/17/17)

First serious down day in ages? Jim Cramer says it's as normal as rain; and he has an umbrella for you.

TheStreet Quant Rating: C (Hold)